Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST002377)
CE NEGATIVE ION MODE (Analysis AN003874)
Metabolite
Structure
F1
F2
Pyruvate
ME562025
NA
1.00
Isethionate
ME562003
1.43
0.57
Sebacate
ME562029
1.44
0.56
Adenylosuccinate
ME561969
0.56
1.44
Citrate
ME561983
0.59
1.41
Adenosine 3^,5^-diphosphate
ME561968
0.61
1.23
3-Ureidopropionate
ME561961
0.67
1.33
ATP
ME561975
0.67
1.33
Tartrate
ME562031
0.71
1.29
cis-Aconitate
ME561982
0.70
1.30
trans-Aconitate
ME562035
0.70
1.30
Mucate
ME562008
1.11
0.89
4-Methyl-2-oxopentanoate
ME561964
1.13
0.87
Glycerophosphate
ME561997
1.13
0.87
Ru5P(D-Ribulose 5-phosphate)
ME562027
1.12
0.88
Isocitrate
ME562004
1.12
0.88
PEP(Phosphoenolpyruvate)
ME562022
1.12
0.88
N-Acetylaspartate
ME562010
1.15
0.85
Taurocholate
ME562032
1.15
0.85
2-Hydroxybutyrate
ME561952
1.17
0.83
3^-AMP
ME561956
1.18
0.82
6-Phosphogluconate
ME561967
1.18
0.82
Pimelate
ME562023
1.22
0.64
Azelate
ME561976
1.25
0.75
Urate
ME562042
1.29
0.71
Glucuronate
ME561995
0.85
1.15
3-(2-Hydroxyphenyl)propionate
ME561955
0.83
1.17
ADP-glucose
ME561972
0.83
1.17
trans-4-Hydroxy-3-methoxycinnamate
ME562034
0.84
1.16
Biotin
ME561977
0.84
1.16
Hippurate
ME562000
0.84
1.16
Cysteine sulfinate
ME561985
0.87
1.13
Butanoate
ME561978
0.84
1.12
Propionate
ME562024
0.84
1.13
ADP-ribose
ME561973
0.81
1.19
Malonate
ME562007
0.80
1.20
3-Indoxyl sulfate
ME561959
0.75
1.25
UDP-N-acetylglucosamine
ME562040
0.76
1.24
F1,6P
ME561988
0.78
1.22
Ribulose 1,5-diphosphate
ME562026
0.77
1.23
3-Hydroxybutyrate
ME561958
0.89
1.11
Orotate
ME562020
0.89
1.11
N-Acetylglutamate
ME562013
0.90
1.10
N-Acetylleucine
ME562014
0.90
1.10
N-Acetylglucosamine 1-phosphate
ME562011
0.96
1.04
4-Oxopentanoate
ME561965
0.96
1.04
FAD
ME561990
0.96
1.04
N-Acetylneuraminate
ME562016
0.95
1.05
N-Acetylglucosamine 6-phosphate
ME562012
0.95
1.05
N-Acetyl-beta-alanine
ME562009
0.95
1.05
ADP
ME561971
0.95
1.05
IDP
ME562001
0.95
1.05
UMP
ME562041
0.93
1.07
UDP-glucuronate
ME562039
0.93
1.07
Trehalose 6-phosphate
ME562036
0.93
1.07
NADP+
ME562018
0.93
1.07
AMP
ME561974
0.93
1.07
Lactate
ME562005
0.93
1.07
N-Acetylmethionine
ME562015
0.94
1.06
O-Phosphoserine
ME562019
0.94
1.06
Glycolate
ME561998
0.91
1.09
UDP
ME562037
0.92
1.08
Succinate
ME562030
0.92
1.08
GMP
ME561999
0.92
1.08
IMP
ME562002
0.92
1.08
Glutarate
ME561996
1.05
0.95
S7P(Sedoheptulose 7-phosphate)
ME562028
1.05
0.95
Carbamoylaspartate
ME561979
1.05
0.97
Malate
ME562006
1.04
0.96
Adipate
ME561970
1.04
0.96
GDP-mannose
ME561994
1.04
0.96
3-Phenyllactate
ME561960
1.08
0.92
XMP(Xanthosine 5^-phosphate)
ME562043
1.06
0.94
2-Oxobutyrate
ME561954
1.06
0.94
DHAP
ME561986
1.06
0.94
CMP
ME561984
1.07
0.93
Threonate
ME562033
1.07
0.93
Pantothenate
ME562021
1.02
0.98
NAD+
ME562017
1.02
0.98
Ethanolamine phosphate
ME561987
1.02
0.98
2-Hydroxyglutarate
ME561953
1.02
0.98
CDP
ME561980
1.02
0.98
G1P (D-Glucose 1-phosphate)
ME561992
1.00
1.00
4-Hydroxy-3-methoxymandelate
ME561963
1.00
1.00
5-Oxoproline
ME561966
1.00
1.00
UDP-glucose
ME562038
0.99
1.01
3-Hydroxy-3-methylglutarate
ME561957
0.99
1.01
G6P
ME561993
0.99
1.01
Fumarate
ME561991
0.98
1.02
F6P
ME561989
0.98
1.02
3-Phosphoglycerate
ME561962
0.98
1.02
CDP-choline
ME561981
0.98
1.02
Factors:
F1
Genotype:Pnpla7-knockout
F2
Genotype:Wild-type
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
This repository is under review for potential modification in compliance with Administration directives
Terms of use
Site map
Contact
NMDR Personnel